Chief Business Officer · PLIANT THERAPEUTICS, INC. (PLRX)

Hans Hull

A named executive officer of PLIANT THERAPEUTICS in every fiscal year CompBrief holds from FY2019 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$2,015,324

Salary $444,392Stock awards $549,360

FY2023: $4,357,277

4th of 5 named executive officers at Pliant Therapeutics by FY2024 total.

5 named officers on file for PLIANT THERAPEUTICS, FY2024

Hans Hull’s pay file — $29

  • 6 fiscal years of pay, line by line
  • 7 equity grants, each cited to its filing
  • PLRX’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how PLIANT THERAPEUTICS’s whole pay program stands against its peers

  • PLIANT THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PLRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2025 (DEF 14A).

Free

Get Hans Hull’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Hans Hull compensation by year

PLIANT THERAPEUTICS Summary Compensation Table · all 6 fiscal years held
In US dollars, as PLIANT THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021FY2022FY2023FY2024
Salary$355,137$372,491$385,735$407,000$427,300$444,392
Bonus$75,000$0$0$0$0$0
Stock awards$0$0$0$1,642,517$1,871,100$549,360
Option awards$268,560$279,025$1,071,142$880,594$1,883,664$811,440
Non-equity incentive$136,369$176,951$185,153$211,640$170,920$195,532
Pension and deferred compensation$0$0$0$0$0$0
All other$11,200$11,400$11,600$13,000$4,293$14,600
Total$846,266$839,867$1,653,630$3,154,751$4,357,277$2,015,324

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PLIANT THERAPEUTICS, INC. DEF 14A filed April 23, 2025, accession 0001746473-25-000089, and prior-year filings.

How this page was built: the PLIANT THERAPEUTICS, INC. filed document, accession 0001746473-25-000089. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2025.

$846K
$840K
$1.7M
$3.2M
$4.4M
$2.0M
FY19
FY20
FY21
FY22
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU36,000$474,120—
RSU31,500$414,855—
Option1,297—$26.50
Option30,469—$11.86
Option39,688—$34.65
Option48,563—$17.44

Per the Outstanding Equity Awards at Fiscal Year-End table in PLIANT THERAPEUTICS, INC.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

PLIANT THERAPEUTICS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Bernard CouliePresident, Chief Executive Officer and Director$6,614,704
Keith CummingsChief Financial Officer$3,099,874
Éric LefebvreChief Medical Officer$2,615,618
Hans Hull · this pageChief Business Officer$2,015,324
Mike OuimetteChief Legal and Compliance Officer and Secretary$1,994,260

The full PLIANT THERAPEUTICS compensation record

free company brief

This page is one person within PLIANT THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the PLIANT THERAPEUTICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PLIANT THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Hans Hull's compensation dossier · One-time report. No refunds.